One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant. - Chippendale L; Freyer CW; Carulli A; Babushok DV; Frey NV; Gill SI; Hexner EO; Luger SM; Martin ME; Porter DL; Stadtmauer EA; Loren AW (Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2024)